The ATF6-EGF Pathway Mediates the Awakening of Slow-Cycling Chemoresistant Cells and Tumor Recurrence by Stimulating Tumor Angiogenesis.

导出 OA

翻译打印收藏纠错

作者： Jaebeom,Cho ^[1] ; Hye-Young,Min ^[1] ; Honglan,Pei ^[2] ; Xuan,Wei ^[1] ; Jeong Yeon,Sim ^[1] ; Shin-Hyung,Park ^[1] ; Su Jung,Hwang ^[3] ; Hyo-Jong,Lee ^[2] ; Sungyoul,Hong ^[4] ; Young Kee,Shin ^[4] ; Ho-Young,Lee ^[2]

作者单位： Creative Research Initiative Center for concurrent control of emphysema and lung cancer, College of Pharmacy, Seoul National University, Seoul 08826, Korea. ^[1] College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea. ^[2] Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Pharmacy, Seoul National University, Seoul 08826, Korea. ^[3] College of Pharmacy, Inje University, Gimhae, Gyungnam 50834, Korea. ^[4]

关键词 angiogenesis chemoresistance slow-cycling cancer cells tumor recurrence

DOI 10.3390/cancers12071772

PMID 32630838

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交